• German Tech Holding entered analyst coverage by First Berlin Equity Research, led by senior analyst Christian Orquera.
• Coverage follows a term sheet to invest in Zirnostics via a planned cash capital increase, with the deal targeted for November 2026.
• Term sheet includes minority protections, an exclusive right to subscribe for an additional 5% through end-2027, anti-dilution protection.
• Investment funding is tied to proceeds from a rights offering of treasury shares, with subscriptions running Oct. 13–27.
• Zirnostics’ zirconium-89 PSMA PET/CT tracer targets higher tumor-to-background contrast; product lacks regulatory approval pending clinical studies.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. German Tech Holding GmbH & Co. KGaA published the original content used to generate this news brief via pressetext (Ref. ID: 202610131051PRESSTXTEUPR__DE88A8296D32B32D6DBB0CBAF4A890383) on October 13, 2026, and is solely responsible for the information contained therein.